HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toru Nakamura Selected Research

Abdominal Wound Closure Techniques

2/2022Effect of triclosan-coated sutures for abdominal wound closure on the incidence of abdominal wound dehiscence: a protocol for an individual participant data meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toru Nakamura Research Topics

Disease

70Neoplasms (Cancer)
09/2022 - 03/2004
25Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 03/2004
17Adenocarcinoma
08/2022 - 03/2004
15Neoplasm Metastasis (Metastasis)
10/2020 - 04/2006
12Hepatocellular Carcinoma (Hepatoma)
11/2021 - 05/2004
11Liver Cirrhosis (Hepatic Cirrhosis)
07/2020 - 03/2006
9Colonic Neoplasms (Colon Cancer)
03/2016 - 05/2005
8Carcinoma (Carcinomatosis)
06/2022 - 12/2006
7Wounds and Injuries (Trauma)
02/2022 - 04/2013
7Stomach Neoplasms (Stomach Cancer)
05/2021 - 11/2013
7Lymphatic Metastasis
01/2021 - 06/2006
6Klatskin Tumor
05/2022 - 08/2014
6Fibrosis (Cirrhosis)
07/2020 - 03/2006
6Cholangiocarcinoma
01/2019 - 07/2014
6Inflammation (Inflammations)
02/2018 - 07/2009
5Hemorrhage
04/2020 - 11/2005
5Schizophrenia (Dementia Praecox)
01/2017 - 11/2014
5Body Weight (Weight, Body)
11/2016 - 04/2006
4Pain (Aches)
05/2022 - 03/2016
4Margins of Excision
01/2021 - 04/2015
4Infections
04/2020 - 01/2002
4Carcinogenesis
01/2016 - 03/2004
4Hyperuricemia
01/2013 - 04/2008
3Liver Failure
06/2022 - 01/2016
3Breast Neoplasms (Breast Cancer)
05/2022 - 01/2005
3Prostatic Neoplasms (Prostate Cancer)
01/2022 - 06/2006
3Pancreatic Fistula (Pancreatic Fistulas)
05/2021 - 12/2018
3Melanoma (Melanoma, Malignant)
09/2020 - 12/2006
3Ascites
12/2019 - 05/2014
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019 - 03/2009
3Surgical Wound Infection
09/2018 - 08/2010
3Primitive Neuroectodermal Tumors (PNET)
12/2017 - 12/2014
3Mental Disorders (Mental Disorder)
12/2016 - 04/2008
3Hypoxia (Hypoxemia)
01/2016 - 06/2012
3Non-alcoholic Fatty Liver Disease
11/2013 - 07/2009
2Bacteremia
09/2022 - 01/2020
2Lung Neoplasms (Lung Cancer)
01/2021 - 01/2018
2Pathologic Constriction (Stenosis)
04/2020 - 11/2018
2Rare Diseases (Rare Disease)
01/2020 - 12/2017
2Wound Infection (Wound Infections)
01/2018 - 04/2013

Drug/Important Bio-Agent (IBA)

9Biomarkers (Surrogate Marker)IBA
01/2021 - 11/2014
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 04/2006
8Proteins (Proteins, Gene)FDA Link
01/2020 - 04/2006
8ErbB Receptors (EGF Receptor)IBA
07/2012 - 12/2006
7AntigensIBA
01/2022 - 01/2005
7Complementary DNA (cDNA)IBA
12/2017 - 03/2004
7Biological ProductsIBA
01/2017 - 04/2005
6erucylphosphocholineIBA
01/2016 - 03/2006
5Uric Acid (Urate)IBA
12/2014 - 04/2008
5Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
02/2008 - 06/2006
4Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2011 - 12/2006
4Irinotecan (Camptosar)FDA LinkGeneric
05/2008 - 12/2006
3Triclosan (pHisoHex)FDA Link
02/2022 - 04/2013
3CarbohydratesIBA
01/2022 - 01/2005
3CytokinesIBA
07/2020 - 04/2010
3Alanine Transaminase (SGPT)IBA
02/2018 - 04/2006
3Fluorouracil (Carac)FDA LinkGeneric
01/2018 - 03/2011
3Peptides (Polypeptides)IBA
12/2017 - 05/2005
3Tumor Biomarkers (Tumor Markers)IBA
12/2017 - 03/2004
3Indicators and Reagents (Reagents)IBA
04/2017 - 03/2015
3pentosidineIBA
01/2017 - 11/2014
3Matrix Metalloproteinases (MMPs)IBA
10/2014 - 07/2007
3Messenger RNA (mRNA)IBA
11/2013 - 05/2004
3Epidermal Growth Factor (EGF)IBA
07/2012 - 12/2006
3Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2012 - 01/2008
3Transforming Growth Factor alpha (TGF-alpha)IBA
07/2008 - 12/2007
3Imatinib Mesylate (Gleevec)FDA Link
01/2008 - 06/2006
3AEE 788 (AEE788)IBA
01/2008 - 12/2006
2VaccinesIBA
05/2022 - 01/2020
2BismuthIBA
05/2022 - 05/2022
2Analgesics (Analgesic Drugs)IBA
05/2022 - 02/2017
2EnzymesIBA
11/2021 - 04/2015
2Untranslated RNA (Noncoding RNA)IBA
02/2021 - 01/2016
2Carcinoembryonic AntigenIBA
01/2021 - 01/2005
2InterferonsIBA
09/2020 - 11/2005
2Carbon Tetrachloride (Tetrachloromethane)IBA
07/2020 - 01/2013
2Phosphotransferases (Kinase)IBA
07/2020 - 06/2006
2Anti-Bacterial Agents (Antibiotics)IBA
04/2020 - 09/2018
2Small Interfering RNA (siRNA)IBA
01/2020 - 05/2008
2GemcitabineFDA Link
11/2019 - 04/2010
2Cisplatin (Platino)FDA LinkGeneric
09/2018 - 04/2010
2LigandsIBA
04/2018 - 02/2008
2Pharmaceutical PreparationsIBA
01/2018 - 11/2006
2Cytosine DeaminaseIBA
01/2018 - 03/2012
2ProdrugsIBA
01/2018 - 03/2011
2Flucytosine (Ancobon)FDA Link
01/2018 - 03/2012

Therapy/Procedure

29Therapeutics
01/2022 - 01/2002
11Drug Therapy (Chemotherapy)
11/2021 - 01/2002
10Pancreatectomy
08/2022 - 03/2014
10Gastrectomy
05/2021 - 12/2015
10Pancreaticoduodenectomy
01/2021 - 06/2014
9Hepatectomy
09/2022 - 02/2015
8Lymph Node Excision (Lymph Node Dissection)
06/2022 - 09/2012
7Transplantation
10/2014 - 03/2006
6Neoadjuvant Therapy
01/2022 - 05/2016
5Sutures (Suture)
02/2022 - 04/2013
5Esophagectomy
09/2021 - 06/2017
4Lasers (Laser)
08/2007 - 03/2004
3Chemoradiotherapy
06/2019 - 04/2015
2Length of Stay
12/2021 - 02/2017